Antibody-dependent cellular cytotoxicity in patients with mycosis fungoides and Sézary syndrome.
D000328:Adult; D000368:Aged; D000818:Animals; D000912:Antibodies, Neoplasm / Q000008:administration & dosage; D000920:Antibody-Dependent Cell Cytotoxicity; D000951:Antigens, Neoplasm / Q000008:administration & dosage; D002460:Cell Line; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008214:Lymphocytes / Q000276:immunology; D008223:Lymphoma / Q000276:immunology; D008297:Male; D012515:Mast-Cell Sarcoma / Q000276:immunology; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000276:immunology*; D011565:Psoriasis / Q000276:immunology; D012513:Sarcoma, Experimental / Q000276:immunology; D012751:Sezary Syndrome / Q000276:immunology*; D012878:Skin Neoplasms / Q000276:immunology*
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm